Cancer Innovation is a high-quality, open access oncology journal publishing innovative papers on all aspects of basic and clinical cancer research. Contact · Editorial Board · Overview · Publish Open Access at No Cost

The two years line is equivalent to journal impact factor ™ (Thomson Reuters) metric. Cites per document, Year, Value. Cites / Doc. (4 years), 2022, 0.000.

Cancer Innovation is a high-quality peer-reviewed open access journal covering key topics in all aspects of cancer research, focusing on emerging ...

The two years line is equivalent to journal impact factor ™ (Thomson Reuters) metric. Cites per document, Year, Value. Cites / Doc. (4 years), 2022, 0.000.

3 сент. 2024 г. · Cancer Innovation latest impact IF is 1.15. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this ...

You can sort the result by Impact factor (ISI and Scopus Citescore) and on title. Filter the results (see facets on the left of the screen) to show only ...

Access 135+ million publications and connect with 20+ million researchers. Join for free and gain visibility by uploading your research.

In 2024, JMIR Cancer received a Journal Impact Factor™ of 3.3 (Source: Journal Citation Reports™ from Clarivate, 2024). JMIR Cancer is indexed in PubMed Central ... Indexing and Impact Factor · Impact Factor of 3.3 · Author Information · Top Articles

New Impact Factor for Translational Cancer Research: 1.5 · Translational Cancer Research 2023 CiteScore Released: 2.1 · Interviews with Outstanding Authors (2024). Prognostic impact of... · The pan-cancer landscape of... · About tcr · Archives

... innovations in cancer treatment and patient care. The journal publishes ... 2023 Impact Factor. 7.7. 2023 5-Year Impact Factor. 0.04083. Eigenfactor Score. Guide for Authors · Past Issues · Articles in Press · Current Issue